Immunotherapy has become standard of care for all stages of NSCLC. However, there is a gap in knowledge on how to select patients for neoadjuvant immunotherapy followed by surgical resection.

The 2023 Multidisciplinary Thoracic Cancers Symposium features:

The goal of this session is to teach attendees the practical aspects of liver contouring. Attendees will be able to practice contouring liver tumors and relevant organs at risk (OAR) both prior to the session and after to evaluate self-improvement.

The goal of this session is to teach attendees the practical aspects of liver contouring. Attendees will be able to practice contouring liver tumors and relevant organs at risk (OAR) both prior to the session and after to evaluate self-improvement.

We will start with a brief review of anatomy in CT and MRI followed by a brief discussion of how to deliver a boost based on the FLAME trial. Then we will follow with a review of the postoperative contouring guidelines and the update to the pelvic lymph nodes contouring guidelines.

We will start with a brief review of anatomy in CT and MRI followed by a brief discussion of how to deliver a boost based on the FLAME trial. Then we will follow with a review of the postoperative contouring guidelines and the update to the pelvic lymph nodes contouring guidelines.

Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies. This session will focus on clinical indications and basics of medical physics and radiobiology (along with Dr. Hobbs).

Radiopharmaceuticals are an increasingly utilized therapeutic option for the treatment of malignancies. This session will focus on clinical indications and basics of medical physics and radiobiology (along with Dr. Hobbs).